Emricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis; ENCORE-LF

Press/Media: Press / Media

PeriodOct 2 2018

Media coverage

1

Media coverage

  • TitleEmricasan, a Caspase Inhibitor, for Treatment of Subjects With Decompensated NASH Cirrhosis; ENCORE-LF
    Media name/outletClinical Trials.gov
    CountryUnited States
    Date10/2/18
    PersonsEric J Lawitz
View all 1
View less